Relationship between immunity to borrelia burgdorferi Outer-surface Protein A (OspA) and lyme arthritis

Clinical Infectious Diseases

Volumn 52, Issue SUPPL. 3, 2011, Pages

  Steere, Allen C ^a   Drouin, Elise E ^a   Glickstein, Lisa J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HLA DR ANTIGEN; OUTER SURFACE PROTEIN A; VACCINE; BACTERIAL VACCINE; LIPOPROTEIN; LYME DISEASE VACCINE; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL IMMUNITY; BORRELIA BURGDORFERI; BORRELIA INFECTION; CELL STIMULATION; CELLULAR IMMUNITY; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; LYME DISEASE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; ANIMAL; ANIMAL MODEL; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; REVIEW; UNITED STATES;

ANIMALS; ANTIGENS, SURFACE; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MODELS, ANIMAL; TH1 CELLS; UNITED STATES;

EID: 79952591597     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq117     Document Type: Article

References (45)

1. Steere AC Lyme disease. N Engl J Med 2001; 345:115-125. (Pubitemid 32640193)
2. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme ar-thritis. Ann Intern Med 1987; 107:725-731.
3. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994; 37:878-888. (Pubitemid 24184540)
4. Dattwyler RJ, Wormser GP, Rush TJ, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr2005; 117:393-397. (Pubitemid 41158819)
5. Steere AC, Angelis SM. Therapy for Lyme arthritis; strategies for the treatment of antibioticrefractory arthritis. Arthritis Rheum 2006; 54:3079-3085.
6. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis. N Engl J Med 1994; 330:229-234. (Pubitemid 24034134)
7. Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC Lack of Borrelia burgdorferi DNA in synovial samples in patients with antibiotic treatmentresistant Lyme arthritis. Arthritis Rheum 1999; 42: 2705-2709. (Pubitemid 30327194)
8. Steere AC, Dwyer E, Winchester R. Association ofchronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990; 323:219-223. (Pubitemid 20225041)
9. Kalish RA, Leong JM, Steere AC Association of treatmentresistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61:2774-2779. (Pubitemid 23182268)
10. Lengl-Janssen B, Strauss AF, Steere AC, Kamradt T. The T helper cell response in Lyme arthritis: differential recognition ofBorrelia burgdorferi outer surface protein A (OspA) in patients with treatmentresistant or treatmentresponsive Lyme arthritis.J Exp Med 1994; 180:2069-2078.
11. Kalish RA, Leong JM, Steere AC Early and late antibody responses to fulllength and truncated constructs of outersurface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun 1995; 63:2228-2235.
12. Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC Association of antibiotic treatmentresistant Lyme arthritis with T cell responses to dominant epitopes of outersurface protein A (OspA) of Borrelia burgdorferi. Arthritis Rheum 1999; 42:1813-1822. (Pubitemid 30257744)
13. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998; 339:209-215. (Pubitemid 28350162)
14. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of re-combinant Borrelia burgdorferi outersurface protein A to prevent Lyme disease. Recombinant outersurface protein A Lyme disease vaccine studyconsortium. N Engl J Med 1998; 339:216-222. [Erratum, N Engl J Med 1998;339:571]. (Pubitemid 28350163)
15. Gross DM, Forsthuber T, TaryLehman M, et al. Identification of LFA-1 as a candidate autoantigen in treatmentresistant Lyme arthritis. Science 1998; 281:703-706. (Pubitemid 28390407)
16. Steere AC, Klitz W, Drouin EE, et al. Antibioticrefractory Lyme ar-thritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.J Exp Med 2006; 203:961-971.
17. Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC Searching for borrelial T cell epitopes associated with antibioticrefractory Lyme arthritis. Mol Immunol 2008; 45:2323-2332.
18. 175 T cell epitope associated with treatmentresistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. J Autoimmun 2004; 23:281-292. (Pubitemid 40292026)
19. Ausubel LJ, O'Connor KC, BaecherAllen C, et al. Characterization of in vivo expanded OspA-specific human T-cell clones. Clin Immunol 2005; 115:313-322. (Pubitemid 40712327)
20. 61-175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibioticresponsive or antibioticrefractory Lyme arthritis. J Immunol 2007; 179:6336-6342.
21. Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC Antibody responses to Borrelia burgdorferi in patients with antibiotic- refractory, antibioticresponsive, or nonantibiotictreated Lyme ar-thritis. Arthritis Rheum 2007; 56:4216-4225. (Pubitemid 350262350)
22. Meyer AL, Trollmo C, Crawford F, et al. Direct enumeration of Borrelia-reactive CD4+ T cells exvivo byusing MHC class II tetramers. Proc Natl Acad Sci USA 2000; 97:11433-11438.
23. Trollmo C, Meyer AL, Steere AC, Hafler DA, Huber BT. Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1ot(L) is a partial agonist for outer surface protein A-reactive T cells. J Immunol 2001; 166:5286-5291. (Pubitemid 32280747)
24. Steere AC, Falk B, Drouin EE, BaxterLowe LA, Hammer J, Nepom GT. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLADR molecules associated with antibiotic treatmentresistant Lyme arthritis. Arthritis Rheum 2003; 48:534-540. (Pubitemid 36278023)
25. Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Mol Immunol 2008; 45:180-189. (Pubitemid 47331642)
26. Ghosh S, Seward R, Costello CE, Stollar BD, Huber BT. Autoanti-bodies from synovial lesions in chronic, antibiotic treatment-re-sistant Lyme arthritis bind cytokeratin-10. J Immunol 2006; 177:2486-2494. (Pubitemid 44201008)
27. Iliopoulou BP, Alroy J, Huber BT. Persistent arthritis in Borrelia burgdorferi-infected HLADR4positive CD28negative mice post-antibiotic treatment. Arthritis Rheum 2008; 58:3892-3901.
28. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master ofregulation. Nat Immunol 2008; 9:239-244. (Pubitemid 351267321)
29. Iliopoulou BP, GuerauDeArellano M, Huber BT. HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of selfperpetuating arthritis. Arthritis Rheum 2009; 60:3831-3840.
30. Feng S, Barthold SW, Bockenstedt LK, Zaller DM, Fikrig E. Lyme disease in human DR4Dw4transgenic mice. J Infect Dis 1995; 172:286-289.
31. Iliopoulou BP, Alroy J, Huber BT. CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the de-velopment ofchronic Lyme arthritis.J Immunol 2007; 179:8076-8082.
32. Shin S, Shin JJ, Strle K, et al. T regulatory cell numbers and function in patients with antibioticrefractory or antibioticresponsive Lyme ar-thritis. Arthritis Rheum 2010; 62:2127-2137.
33. Keane-Myers A, Nickell SP. T cell subsetdependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995; 154:1770-1776.
34. Kang I, Barthold SW, Persing DH, Bockenstedt LK. Thelpercell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 1997; 65:3107-3111. (Pubitemid 27342385)
35. Matyniak JE, Reiner SL. T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995; 181:1251-1254.
36. Crandall H, Dunn DM, Ma Y, et al. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J Immunol 2006; 177:7930-7942. (Pubitemid 44846309)
37. Shin JJ, Glickstein LJ, Steere AC High levels of inflammatory che-mokines and cytokines in joint fluid and synovial tissue throughout the course of antibioticrefractory Lyme arthritis. Arthritis Rheum 2007; 56:1325-1333.
38. Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat Rev Im-munol 2004; 4:143-152. (Pubitemid 38209208)
39. Sikand VK, Halsey N, Krause PJ, et al. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial. Pediatrics 2001; 108:123-128. (Pubitemid 32592015)
40. Rose CD, Fawcett PT, Gibney KM. Arthritis following recombinant outer surface protein A vaccination for Lyme disease. J Rheumatol 2001; 28:2555-2557. (Pubitemid 33031993)
41. Lathrop SL, Ball R, Haber P, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July2000. Vaccine 2002; 20:1603-1608. (Pubitemid 34169801)
42. Ball R, Shadomy SV, Meyer A, et al. HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination. Arthritis Rheum 2009; 60:1179-1186.
43. Croke CL, Munson EL, Lovrich SD, et al. Occurrence of severe de-structive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 2000; 68:658-663. (Pubitemid 30056520)
44. Schoen RT, Meurice F, Brunet CM, et al. Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease. J Infect Dis 1995; 172:1324-1329.
45. Jones KL, McHugh G, Glickstein L, Steere AC Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: high frequency of ribosomal RNA intergenic spacer type 1 strains in antibioticrefractory arthritis. Arthritis Rheum 2009; 60:2174-2178.